SCHEMBL10914780

SCHEMBL10914780

CC(C)(C)OC(=O)CN1CCCCC[C@@H](N)C1=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G10 O15496 2/20 0.43
PLA2G5 P39877 2/20 0.43
MMP1 P03956 6/20 0.39
MMP3 P08254 6/20 0.39
F2 P00734 1/20 0.37
F10 P00742 1/20 0.37
PRSS1 P07477 1/20 0.37
HPGD P15428 1/20 0.36
PDE4A P27815 2/20 0.36
PDE4B Q07343 2/20 0.36
PDE4C Q08493 2/20 0.36
PDE4D Q08499 2/20 0.36
EPHX1 P07099 1/20 0.35
ACE P12821 1/20 0.34
MEN1 O00255 1/20 0.34
ALDH1A1 P00352 1/20 0.34
MAPT P10636 1/20 0.34
KMT2A Q03164 1/20 0.34
HTR4 Q13639 1/20 0.34
DPP4 P27487 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10913716 1.00 PLA2G10 (0.43) PLA2G10PLA2G5MMP1MMP3F2
SCHEMBL10913722 1.00 PLA2G10 (0.43) PLA2G10PLA2G5MMP1MMP3F2
SCHEMBL10895110 1.00 PLA2G10 (0.43) PLA2G10PLA2G5MMP1MMP3F2
SCHEMBL10691419 0.99 PLA2G10 (0.43) PLA2G10PLA2G5MMP1MMP3F2
Pidolic Acid SCHEMBL10914420 0.86 PLA2G10 (0.39) PLA2G10PLA2G5MMP1MMP3F2
Pidolic Acid SCHEMBL10914329 0.86 PLA2G10 (0.39) PLA2G10PLA2G5MMP1MMP3F2
SCHEMBL10896372 0.84 PLA2G10 (0.43) PLA2G10PLA2G5MMP1MMP3F2
SCHEMBL10911583 0.84 PLA2G10 (0.43) PLA2G10PLA2G5MMP1MMP3F2
SCHEMBL10914619 0.84 PLA2G10 (0.43) PLA2G10PLA2G5MMP1MMP3F2
SCHEMBL12495091 0.83 MMP1 (0.52) MMP1MMP3F2ACEMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4587050-A Substituted enantholactam derivatives as antihypertensives MERCK & CO., INC. (US) 1986-05-06 US disclosed
EP-0046289-A2 Substituted enantholactam derivatives as antihypertensives, a process for preparing and a pharmaceutical composition containing them, and intermediates MERCK & CO. INC. (US) 1982-02-24 EP disclosed